Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2002-05-28
2003-02-11
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S454000, C424S464000, C424S474000, C424S480000, C424S482000
Reexamination Certificate
active
06517865
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to non-animal polymer compositions suitable for film forming, particularly hard and soft capsules, comprising water soluble cellulose ethers, hydrocolloids and sequestering agents.
2. Description of Related Art
Capsules are widely used in the pharmaceutical industry as well as in the health food supplement market. The main usage thereof is as dosage form for solid, semi-solid, liquid, pellet or herbal preparations. A primary objection of these dosage forms is to have a good disintegration after being administered in order to enable an effective dissolution of the active substances in the appropriate digestive organ. Consequently, this disintegration characteristic has to remain stable over time when finished products are stored prior to use.
The traditional material for forming the capsule shell is gelatin, because it has the correct and quite ideal properties. Nevertheless, gelatin has some disadvantages which make it necessary to have other capsule shell materials available. A major unfavorable aspect is the animal origin of gelatin. Other disadvantages are the inconveniences of relatively high water content (10-17%) and the loss of elasticity with decreasing water content. Furthermore gelatin capsules are sensitive to heat and humidity which affects the usability of the product. In particular, soft gelatin capsules are known to aggregate under hot and humid conditions. Under dry conditions gelatin films may induce static charge build up affecting later processing.
As a gelatin substitute the use of water soluble film forming cellulose derivatives is widely described in the literature. Reports of capsules made from cellulose derivatives refer to poor disintegration in vivo especially when compared with gelatin. To overcome this drawback in EP0714656 it is suggested to use hydroxypropylmethylcellulose (HPMC) with a viscosity of 2.4 to 5.4 centistokes in 2% aqueous solution at 20° C. with carrageenan as gelling agent and calcium or potassium ions as co-gelling agent. However the very low viscosity of HPMC resulting from lower molecular weight chains induces higher film brittleness. Furthermore, the use of this composition results in an undesirable loss of transparency of the film. Attempts to improve transparency are disclosed in EP0592130 by exposing BPMC to UV radiation prior to capsule processing.
SUMMARY OF THE INVENTION
It has been found that a polymer film composition for capsules wherein the ratios of cellulose ethers, hydrocofloids and sequestering agents are 90 to 99.98% by weight of a cellulose ether or mixture of cellulose ethers with a water content of 2 to 10%, 0.01 to 5% by weight of a hydrocolloid or mixtures of hydrocofloids, and 0.01 to 5% by weight of a sequestering agent or agents do not have the mentioned disadvantages.
REFERENCES:
patent: 5431917 (1995-07-01), Yamamoto et al.
Cade Dominique
He Xiongwei
Scott Robert
Federman Evan J.
Page Thurman K.
Sheikh Humera N.
Warner-Lambert & Company
LandOfFree
Polymer film compositions for capsules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer film compositions for capsules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer film compositions for capsules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3162701